1. What Is the Strep Rapid Test Market?
The Strep Rapid Test Market comprises point-of-care immunoassay devices that detect Group A Streptococcus antigen in throat swab specimens. It is a medical-device and single-use-consumable market spanning visual-read and instrument-assisted test formats. The market includes rapid antigen-detection strep tests, rapid molecular-detection strep tests, and reflex-to-culture workflow combinations. Digital immunoassay strep tests with sensitivity approaching throat-culture methods represent the current technology frontier. Scope spans symptomatic pharyngitis testing, antibiotic-stewardship-guided workflows, and screening-and-confirmation testing approaches for pediatric and adult patients. These tests enable same-visit antibiotic-prescribing decisions in physician offices, urgent-care centers, and pharmacy clinics. End users include pediatric practices and clinics, physician offices, urgent-care centers, and pharmacies and retail clinics. In-vitro-diagnostic manufacturers distribute CLIA-waived rapid-strep tests through physician office and pharmacy procurement channels. The scope excludes throat-culture diagnostic testing requiring overnight laboratory incubation and broader molecular respiratory panel tests.
2. Strep Rapid Test Market Size & Forecast
3. Emerging Technologies
- AI-Powered Strep swift Test Frameworks analyze real-time operational data streams to predict workflow demand accurately. Enterprise teams deploy automated machine learning models to accelerate processing throughput by forty percent.
- Cloud-Native Strep swift Test Architecture enables scalable multi-tenant asset management across distributed cloud nodes. System administrators utilize containerized microservices to lower infrastructure latency and maintain system uptime.
- Zero-Trust Strep swift Test Protocols enforce continuous identity verification and cryptographic encryption across all user access points. Security teams integrate automated policy enforcement software to mitigate cyber threats across enterprise networks.
- Real-Time Strep swift Test SDKs process high-volume transactional metrics to generate actionable business intelligence dashboards. Executive decision-makers utilize predictive telemetry feeds to optimize resource allocation and strategic planning.
Such innovations are driving change across adjacent industries too. Discover more in our Covid 19 Rapid Test Market.
4. Key Market Opportunity
A key opportunity in the Strep Rapid Test Market is molecular-sensitivity antigen testing that closes the accuracy gap responsible for the reflex-to-culture confirmation step most rapid strep antigen tests still require after a negative result. Standard rapid antigen strep tests miss enough true positive cases that clinical guidelines require sending a negative rapid result to backup culture confirmation, adding a multi-day delay before a negative patient can be confidently cleared. Molecular-sensitivity rapid platforms from Cepheid and Quidel are achieving PCR-level accuracy within a point-of-care antigen format, reducing the false-negative rate that currently drives mandatory reflex-to-culture confirmation. Clinics adopting molecular-sensitivity rapid strep testing will eliminate the reflex-culture confirmation delay for most negative results, and treat or clear patients within a single visit rather than waiting days for backup culture results.
5. Top Companies in the Strep Rapid Test Market
The following organisations hold leading positions in the Strep Rapid Test Market. The full report provides revenue share, SWOT analysis, and competitive benchmarking for each player.
- Agena Bioscience
- Exact Sciences (Cologuard)
- Guardant Health
- LabCorp (Myriad)
- Grail (Illumina)
- BD (Veritor)
- Quidel (Sofia)
- bioMerieux (VIDAS)
- Roche (cobas)
- Abbott (ID NOW)
- Siemens Healthineers (CLINITEK)
- Meridian Bioscience (Illuminate)
- Thermo Fisher Scientific (AcroMetrix)
6. Market Segmentation
The Strep Rapid Test Market is analysed across 6 segmentation dimensions. Revenue data, growth rates, and competitive intensity by sub-segment are available in the full report.
| Segmentation | Sub-Segments |
|---|---|
| By Diagnostic Approach | Antigen-Detection Strep Test Lateral-Flow Antigen Strep Digital Antigen Strep Molecular-Detection Strep Test Reflex-to-Culture Strep Workflow |
| By Patient Group | Pediatric Strep Testing Pharyngitis Pediatric Strep Recurrent Pediatric Strep Adult Strep Testing |
| By Result Readout | Visual Qualitative Strep Result Standard Visual Qualitative Strep Result Premium Visual Qualitative Strep Result Digital Instrument Strep Result |
| By Clinical Pathway | Symptomatic-Pharyngitis Strep Testing Standard Symptomatic-Pharyngitis Strep Testing Premium Symptomatic-Pharyngitis Strep Testing Screening and Confirmation Strep Testing Antibiotic-Stewardship Strep Testing |
| By End User | Pediatric Practices and Clinics Large Pediatric Practices and Clinics Community Pediatric Practices and Clinics Physician Offices Urgent-Care Centers Pharmacies and Retail Clinics |
| By Geography | North America Europe Asia Pacific Latin America Middle East and Africa |
7. Key Market Trends (2026–2034)
Three major forces are shaping the Strep Rapid Test Market trajectory over the forecast period:
Pharyngitis-Diagnosis Demand Is Sustaining Strep Rapid Testing.Rapid strep diagnosis guiding antibiotic decisions sustains strep rapid testing across primary and urgent care. Abbott and Quidel expanded rapid strep diagnostic tests in 2024 for rapid group A strep diagnosis in primary and urgent care.
Molecular Rapid Strep Tests Are Advancing Diagnosis Accuracy.Rapid molecular strep tests are advancing accurate rapid strep diagnosis improving antibiotic stewardship. Abbott expanded ID NOW rapid molecular strep testing in 2024, and Quidel advanced molecular strep tests improving rapid strep diagnosis and stewardship.
Strep Rapid Testing Is Integrating With Point-of-Care Systems.Strep rapid testing is increasingly connected with point-of-care and clinical systems for integrated rapid results. Abbott and Quidel expanded rapid strep test integration in 2024 connecting point-of-care strep results to clinical systems and stewardship.
For related market intelligence, see the Influenza Rapid Test Market.
8. Segmental Analysis
By diagnostic approach, the antigen-detection strep test segment dominated the Strep swift Test Market in 2025, driven by established commercial market presence, proven product reliability, and widespread operational adoption. Commercial enterprise buyers and industry procurement managers continue expanding procurement volumes for established solution categories to ensure operational continuity and supply chain integration. The lateral-flow antigen strep segment is the fastest-growing diagnostic approach category, driven by advancing technological capabilities, cost optimization objectives, and shifting commercial demand. Corporate strategy executives and innovation procurement teams are increasing adoption of advanced product tiers to capture productivity improvements and expand market coverage.
By patient group, the pediatric strep testing segment dominated the Strep swift Test Market in 2025, driven by established commercial market presence, proven product reliability, and widespread operational adoption. Commercial enterprise buyers and industry procurement managers continue expanding procurement volumes for established solution categories to ensure operational continuity and supply chain integration. The pharyngitis pediatric strep segment is the fastest-growing patient group category, driven by advancing technological capabilities, cost optimization objectives, and shifting commercial demand. Corporate strategy executives and innovation procurement teams are increasing adoption of advanced product tiers to capture productivity improvements and expand market coverage.
9. Regional Analysis
Regional demand patterns across the Strep Rapid Test Market reflect differences in regulation, technological maturity, and capital investment.
Largest Market Share
North America dominated the Strep Rapid Test Market in 2025, with a market share of 49.10% of overall global revenue. Early commercial adoption of advanced technological platforms, mature enterprise infrastructure, and high regional technology spending drive market leadership. High consumer per-capita income and extensive presence of major industry solution providers reinforce ongoing dominance across the territory. The region is expected to retain its top revenue-contributing position through 2034 propelled by ongoing corporate infrastructure investments.
Highest CAGR Region
Asia Pacific is expected to register the highest CAGR of 10.70% during the forecast period from 2025 to 2034. Swift expansion of high-speed 5G mobile communications and surging digital infrastructure investments across China, India, and Southeast Asia fuel market expansion. Expanding urban middle-class populations and rising commercial technology adoption across developing Asian economies enable millions of new users. Regional service providers are scaling infrastructure deployments to capture expanding commercial demand across emerging Asian markets.
10. Full Report with Exclusive Insights
The complete published market report includes an in-depth analysis of market dynamics, industry trends, competitive landscape, regional outlook, and future growth opportunities. The study provides detailed market sizing and forecasts across key segments and geographies, along with comprehensive insights into drivers, restraints, opportunities, challenges, technological advancements, regulatory landscape, and evolving consumer and industry trends. The report also features company profiles, strategic developments, market share analysis, and actionable recommendations to support informed business decision-making. Additionally, the syndicated report package typically includes forecast datasets, charts and figures, research methodology, and analyst support for strategic interpretation and planning.
Advanced Strategic & Custom Intelligence
In addition to the standard syndicated report package, TrendX Insights can provide the following advanced strategic analyses and customized intelligence solutions for any market:
Standard Report Coverage
- • Competitor Analysis
- • Country Trade Analysis
- • Import & Export Analysis
- • Porter’s Five Forces Analysis
- • SWOT Analysis by Companies
- • TrendX Insights Quadrant Positioning
- • Pricing Analysis
- • Detailed Macro-Economic Indicators Assessment
- • List of Raw Material Suppliers
- • Regulatory Framework Assessment
- • Supply Chain Resilience Mapping
- • Value Chain Analysis
- • Technology Adoption Trends and Innovation Tracking
- • Custom Company Profiling and Benchmarking
Exclusive Sections With Additional Cost
- • Agentic AI Readiness Score
- • TAM, SAM, and SOM Analysis
- • AI Act & Privacy Compliance Audit
- • Channel Partner Ecosystem Mapping
- • China + 1 Strategy Analysis
- • Circular Economy Opportunities Assessment
- • Competitor Benchmarking KPI Analysis
- • Country-Level Opportunity Mapping
- • Digital Maturity Matrix
- • Ecosystem Interdependency Mapping
- • ESG & Decarbonization Roadmap
- • Geopolitical Friction Scorecard
- • Geopolitical Risk Assessment
- • Humanoid Workforce Impact Analysis
- • Investment Heatmap
- • List of Distributors and Channel Partners
- • Market Entry Strategy Assessment
- • Mergers & Acquisitions (M&A) Analysis
- • Patent & Intellectual Property (IP) Analysis
- • Pilot Project Analysis
- • Potential High-Growth Region/Country Investment Assessment
- • Product Comparison Analysis
- • Product Revenue Analysis
- • R&D Investment Analysis in Emerging Technologies
- • Raw Material Scarcity Forecast
Note: For highly customized requirements, deeper strategic assessments, company-specific intelligence, or tailored consulting support, please contact TrendX Insights.
Full Report with Exclusive Insights
Available to clients on request
Explore Our Published Reports Library
This page covers market-level data estimates. For comprehensive published research reports including full methodology, primary data, and detailed company profiles, browse the TrendX Insights Published Reports Library.
Visit Published Reports Library ›11. Related Market Reports
Frequently Asked Questions
The Strep Rapid Test Market was valued at USD 3.80 Bn in 2025 and is projected to reach USD 8.12 Bn by 2034, growing at a CAGR of 8.80% over the 2026–2034 forecast period.
The Strep Rapid Test Market is projected to grow at a CAGR of 8.80% from 2026 to 2034.
North America dominated the Strep Rapid Test Market in 2025, with a market share of 49.10% of overall global revenue.
The leading companies in the Strep Rapid Test Market include Agena Bioscience, Exact Sciences (Cologuard), Guardant Health, LabCorp (Myriad), Grail (Illumina), BD (Veritor), Quidel (Sofia), bioMerieux (VIDAS), Roche (cobas), Abbott (ID NOW), Siemens Healthineers (CLINITEK), Meridian Bioscience (Illuminate), Thermo Fisher Scientific (AcroMetrix).
Pharyngitis-diagnosis demand is sustaining strep rapid testing.
By diagnostic approach, the antigen-detection strep test segment dominated the Strep swift Test Market in 2025, driven by established commercial market presence, proven product reliability, and widespread operational adoption.
How to Order
Purchasing a TrendX Insights report is straightforward. Our process is designed to be transparent and risk-free for buyers, with a 20% upfront model and full delivery before the balance payment.
This is the price of the syndicated report. Any custom inclusions beyond the Table of Contents will be scoped and priced separately. For the full list of what is covered in the syndicated report, refer to the Table of Contents tab.
A curated, condensed version of this report for students, researchers, and academic institutions. Ideal for thesis work, dissertations, and academic projects. Delivered as PDF to your institutional email.
Valid student ID or institutional email required. For educational and non-commercial use only.